Drug Trial Radar · NCT02487550
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
Last checked: Nov 19, 2026Latest source record: Jul 1, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Aug 2015
Primary completion
Jul 2028
Study completion Jul 2030
Sponsor
- Lead sponsor
- The First People's Hospital of ChangzhouAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.
Conditions
- Renal Neoplasma
Interventions
DC-CIKBiological
Patients with renal cell carcinoma will receive autologous dendritic cells loaded with autologous tumor lysate (dendritic cell vaccine) by venous infusion of CIK cells.
IL-2/IFN-αBiological
Patients with renal cell carcinoma will receive IL-2/IFN-α by venous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free timeTime frame: 3 months
- Overall-survival timeTime frame: 3 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.